WO2007000337A8 - Derives bicycliques utilises en tant qu'inhibiteurs de p38 kinase - Google Patents

Derives bicycliques utilises en tant qu'inhibiteurs de p38 kinase

Info

Publication number
WO2007000337A8
WO2007000337A8 PCT/EP2006/006253 EP2006006253W WO2007000337A8 WO 2007000337 A8 WO2007000337 A8 WO 2007000337A8 EP 2006006253 W EP2006006253 W EP 2006006253W WO 2007000337 A8 WO2007000337 A8 WO 2007000337A8
Authority
WO
WIPO (PCT)
Prior art keywords
kinase inhibitors
bicyclic derivatives
derivatives
bicyclic
meanings
Prior art date
Application number
PCT/EP2006/006253
Other languages
German (de)
English (en)
Other versions
WO2007000337A1 (fr
Inventor
Rosales Carmen Almansa
Bernado Marina Virgili
Original Assignee
Palau Pharma Sa
Rosales Carmen Almansa
Bernado Marina Virgili
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Palau Pharma Sa, Rosales Carmen Almansa, Bernado Marina Virgili filed Critical Palau Pharma Sa
Publication of WO2007000337A1 publication Critical patent/WO2007000337A1/fr
Publication of WO2007000337A8 publication Critical patent/WO2007000337A8/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)

Abstract

L'invention se rapporte à de nouveaux dérivés bicycliques de formule (I), dans laquelle les significations des différents substituants sont précisées dans la description. Ces composés sont utiles en tant qu'inhibiteurs de p38 kinase.
PCT/EP2006/006253 2005-06-29 2006-06-28 Derives bicycliques utilises en tant qu'inhibiteurs de p38 kinase WO2007000337A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05380142 2005-06-29
EP05380142.9 2005-06-29

Publications (2)

Publication Number Publication Date
WO2007000337A1 WO2007000337A1 (fr) 2007-01-04
WO2007000337A8 true WO2007000337A8 (fr) 2007-04-19

Family

ID=35115929

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/006253 WO2007000337A1 (fr) 2005-06-29 2006-06-28 Derives bicycliques utilises en tant qu'inhibiteurs de p38 kinase

Country Status (2)

Country Link
AR (1) AR055345A1 (fr)
WO (1) WO2007000337A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007024283A1 (de) 2007-05-23 2008-11-27 Lothar Ernst Wilhelm Weber Mittel zum Abbau von Schadstoffen, insbesondere aus der Raumluft
EP1992344A1 (fr) 2007-05-18 2008-11-19 Institut Curie P38 alpha comme cible therapeutique pour les maladies associées á une mutation de FGFR3
US10513515B2 (en) 2017-08-25 2019-12-24 Biotheryx, Inc. Ether compounds and uses thereof
CA3106239A1 (fr) 2018-07-27 2020-01-30 Biotheryx, Inc. Composes bifonctionnels agissant par agonisme sur des cdk
CN110498759A (zh) * 2019-09-12 2019-11-26 天津瑞岭化工有限公司 异吲哚啉酮类化合物的合成方法
WO2021146543A1 (fr) * 2020-01-15 2021-07-22 The Trustees Of Princeton University Inhibiteurs de glucose-6-phosphate déshydrogénase et leurs utilisations
WO2021222150A2 (fr) 2020-04-28 2021-11-04 Anwita Biosciences, Inc. Polypeptides d'interleukine-2 et protéines de fusion de ceux-ci, ainsi que leurs compositions pharmaceutiques et leurs applications thérapeutiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006526648A (ja) * 2003-06-02 2006-11-24 アボット・ラボラトリーズ キナーゼ阻害剤としてのイソインドリン−１−オン化合物
WO2005039564A1 (fr) * 2003-10-02 2005-05-06 Vertex Pharmaceuticals Incorporated Composes phtalimide utiles en tant qu'inhibiteurs de proteine kinase
JP2007008816A (ja) * 2003-10-15 2007-01-18 Ube Ind Ltd 新規イソキノリン誘導体

Also Published As

Publication number Publication date
WO2007000337A1 (fr) 2007-01-04
AR055345A1 (es) 2007-08-22

Similar Documents

Publication Publication Date Title
WO2007000339A8 (fr) Derives bicycliques en tant qu’inhibiteurs de kinase p38
WO2007000340A3 (fr) Derives bicycliques utilises en tant qu'inhibiteurs de kinase p38
TW200618800A (en) Heterocyclic compounds
MX2009010595A (es) Derivados de pirrolopirimidina.
WO2004076450A8 (fr) Derives de pyrazolopyridine
MX2009007302A (es) Derivados de purina.
WO2005074603A3 (fr) Utilisation d'aminobenzoxazoles comme agents therapeutiques
TW200800956A (en) 2-Aminopyrimidine derivatives
WO2008110355A8 (fr) Dérivés de quinoléine en tant que fongicides
WO2007023110A3 (fr) Inhibiteurs de la map-kinase p38 et ses methodes d'utilisation
WO2006044687A3 (fr) Inhibiteurs de kinase
WO2006072615A3 (fr) Triazolophtalazines
TW200637837A (en) Fungicides
WO2007016674A3 (fr) Aryl pyridines et procédés pour leur utilisation
WO2009019015A8 (fr) Nouveaux herbicides
WO2006072612A3 (fr) Triazolophthalazines
WO2006103277A3 (fr) Piperidines substituees
UA101963C2 (en) 4-amino-pyrimidine derivatives
WO2008151828A3 (fr) Nouveaux microbiocides
WO2007000337A8 (fr) Derives bicycliques utilises en tant qu'inhibiteurs de p38 kinase
WO2008054956A3 (fr) Inhibiteurs de kinases
WO2008104473A3 (fr) Inhibiteurs de kinase et procédés d'utilisation de ces derniers
WO2009003672A3 (fr) Nouveaux microbiocides
NO20082105L (no) Pyrazoloisokinolinderivater
WO2009030450A8 (fr) Nouveaux herbicides

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase in:

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06762241

Country of ref document: EP

Kind code of ref document: A1